The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

insulin human injection, USP, recombinant DNA origin National Museum of American History Humulin R, Regular, insulin human injection, USP, recombinant DNA origin National Museum of American History ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

PUTRAJAYA: The Health Ministry (MOH) will still be able to prescribe human insulin to patients until the end of the year, assured its minister Datuk Seri Dr Dzulkefly Ahmad. This was despite the ...

It is now widely recognised that host–microbiome interactions play a major role in the control of energy metabolism and ...

Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin ... around R$ 800 million ...

No risk of transferring infections. More effective at treating diabetes as animal insulin is different to human insulin. No ethical issues concerning the use of animals.

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...